Chromosomal Aberration Arises During Somatic Reprogramming to Pluripotent Stem Cells

Overview

Journal Cell Div

Publisher Biomed Central

Date 2020 Dec 9

PMID 33292330

Citations 10

Authors

Xinyu Liu

Conghui Li

Kang Zheng

Xiaofeng Zhao

Xiaofeng Xu

Aifen Yang

Min Yi

Huaping Tao

Binghua Xie

Mengsheng Qiu

Junlin Yang

Affiliations

Soon will be listed here.

Abstract

Background: Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) has opened new therapeutic possibilities. However, karyotypic abnormalities detected in iPSCs compromised their utility, especially chromosomal aberrations found at early passages raised serious safety concerns. The mechanism underlying the chromosomal abnormality in early-passage iPSCs is not known.

Methods: Human dermal fibroblasts (HDFs) were stimulated with KMOS (KLF4, cMYC, OCT4 and SOX2) proteins to enhance their proliferative capacity and many vigorous clones were obtained. Clonal reprogramming was carried out by KMOS mRNAs transfection to confirm the 'chromosomal mutagenicity' of reprogramming process. Subculturing was performed to examine karyotypic stability of iPSCs after the re-establishment of stemness. And antioxidant N-acetyl-cysteine (NAC) was added to the culture medium for further confirmming the mutagenicity in the first few days of reprogramming.

Results: Chromosomal aberrations were found in a small percentage of newly induced iPS clones by reprogramming transcription factors. Clonal reprogramming ruled out the aberrant chromosomes inherited from rare karyotypically abnormal parental cell subpopulation. More importantly, the antioxidant NAC effectively reduced the occurrence of chromosomal aberrations at the early stage of reprogramming. Once iPS cell lines were established, they restored karyotypic stability in subsequent subculturing.

Conclusions: Our results provided the first line of evidence for the 'chromosomal mutagenicity' of reprogramming process.

Citing Articles

Endocannabinoid system upregulates the enrichment and differentiation of human iPSC- derived spermatogonial stem cells via CB2R agonism.

Gizer M, Onen S, Erol O, Aerts-Kaya F, Recber T, Nemutlu E Biol Res. 2025; 58(1):13.

PMID: 40069895 PMC: 11900634. DOI: 10.1186/s40659-025-00596-4.

Generation of Retinal Ganglion Cells from Reprogrammed Keratocytes of Non-Glaucoma and Glaucoma Donors.

Hameed S, Sharma T Curr Protoc. 2025; 5(1):e70091.

PMID: 39781605 PMC: 11713219. DOI: 10.1002/cpz1.70091.

Disease models of Leigh syndrome: From yeast to organoids.

Henke M, Prigione A, Schuelke M J Inherit Metab Dis. 2024; 47(6):1292-1321.

PMID: 39385390 PMC: 11586605. DOI: 10.1002/jimd.12804.

Cell Transplantation for Repair of the Spinal Cord and Prospects for Generating Region-Specific Exogenic Neuronal Cells.

Roman A, Huntemer-Silveira A, Waldron M, Khalid Z, Blake J, Parr A Cell Transplant. 2024; 33():9636897241241998.

PMID: 38590295 PMC: 11005494. DOI: 10.1177/09636897241241998.

Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine.

Gropman A, Uittenbogaard M, Chiaramello A Neurotherapeutics. 2024; 21(1):e00311.

PMID: 38266483 PMC: 10903101. DOI: 10.1016/j.neurot.2023.e00311.

References

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

Weissbein U, Benvenisty N, Ben-David U . Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol. 2014; 204(2):153-63. PMC: 3897183. DOI: 10.1083/jcb.201310135. View

Ruiz S, Gore A, Li Z, Panopoulos A, Montserrat N, Fung H . Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming. Nat Commun. 2013; 4:1382. PMC: 3856317. DOI: 10.1038/ncomms2381. View

Aladjem M, Spike B, Rodewald L, Hope T, Klemm M, Jaenisch R . ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol. 1998; 8(3):145-55. DOI: 10.1016/s0960-9822(98)70061-2. View

Kawamura T, Suzuki J, Wang Y, Menendez S, Morera L, Raya A . Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009; 460(7259):1140-4. PMC: 2735889. DOI: 10.1038/nature08311. View

Chappidi N, De Gregorio G, Ferrari S . Replication stress-induced Exo1 phosphorylation is mediated by Rad53/Pph3 and Exo1 nuclear localization is controlled by 14-3-3 proteins. Cell Div. 2019; 14:1. PMC: 6318887. DOI: 10.1186/s13008-018-0044-2. View

Varum S, Rodrigues A, Moura M, Momcilovic O, Easley 4th C, Ramalho-Santos J . Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One. 2011; 6(6):e20914. PMC: 3117868. DOI: 10.1371/journal.pone.0020914. View

Yang J, Yang Y . Plasmid size can affect the ability of Escherichia coli to produce high-quality plasmids. Biotechnol Lett. 2012; 34(11):2017-22. DOI: 10.1007/s10529-012-0994-4. View

Yoshihara M, Oguchi A, Murakawa Y . Genomic Instability of iPSCs and Challenges in Their Clinical Applications. Adv Exp Med Biol. 2020; 1201:23-47. DOI: 10.1007/978-3-030-31206-0_2. View

10.

Momcilovic O, Knobloch L, Fornsaglio J, Varum S, Easley C, Schatten G . DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One. 2010; 5(10):e13410. PMC: 2955528. DOI: 10.1371/journal.pone.0013410. View

11.

Liu D, Shaukat Z, Saint R, Gregory S . Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll. Oncotarget. 2015; 6(36):38552-65. PMC: 4770720. DOI: 10.18632/oncotarget.6035. View

12.

Esteban M, Pei D . Vitamin C improves the quality of somatic cell reprogramming. Nat Genet. 2012; 44(4):366-7. DOI: 10.1038/ng.2222. View

13.

Ji J, Ng S, Sharma V, Neculai D, Hussein S, Sam M . Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells. 2011; 30(3):435-40. DOI: 10.1002/stem.1011. View

14.

Ganem N, Godinho S, Pellman D . A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009; 460(7252):278-82. PMC: 2743290. DOI: 10.1038/nature08136. View

15.

Chen Q, Shi X, Rudolph C, Yu Y, Zhang D, Zhao X . Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines. Chromosome Res. 2011; 19(7):857-68. DOI: 10.1007/s10577-011-9239-y. View

16.

Mujoo K, Pandita R, Tiwari A, Charaka V, Chakraborty S, Singh D . Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination. Stem Cell Reports. 2017; 9(5):1660-1674. PMC: 5831054. DOI: 10.1016/j.stemcr.2017.10.002. View

17.

Mayshar Y, Ben-David U, Lavon N, Biancotti J, Yakir B, Clark A . Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010; 7(4):521-31. DOI: 10.1016/j.stem.2010.07.017. View

18.

Cheng L, Hansen N, Zhao L, Du Y, Zou C, Donovan F . Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell. 2012; 10(3):337-44. PMC: 3298448. DOI: 10.1016/j.stem.2012.01.005. View

19.

Abyzov A, Mariani J, Palejev D, Zhang Y, Haney M, Tomasini L . Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature. 2012; 492(7429):438-42. PMC: 3532053. DOI: 10.1038/nature11629. View

20.

Martins-Taylor K, Nisler B, Taapken S, Compton T, Crandall L, Montgomery K . Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol. 2011; 29(6):488-91. DOI: 10.1038/nbt.1890. View